Impact of anti-tumor necrosis factor antibodies treatment on the semen quality of inflammatory bowel diseases patients

Impact of anti-tumor necrosis factor antibodies treatment on the semen quality of inflammatory bowel diseases patients - AntiTNF and semen quality in IBD patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33788

Enrollment

Registered

2009-05-27

Start date

2009-12-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fertility reproduction

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - male IBD patients with an absolute indication and no contra-indication for anti-TNF medication - age between 18 and 50 years - informed consent

Exclusion criteria

Exclusion criteria: - severe disease activity - Crohn`s Disease Activity Index >300 - incapacity to understand the informed consent - previously documented sub/infertility

Design outcomes

Primary

Measure	Time frame
- changes from the baseline (prior the treatment) semen quality and quantity in the 3rd and 6th month of the antiTNF treatment	—

Countries

Netherlands

Outcome results